PROXEON BIOSYSTEMS ApS: Financial statements 2016
CVR: 26848024
PROXEON BIOSYSTEMS ApS (CVR 26848024) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 39,918,221 and a net result of DKK 31,081,178 compared with DKK 50,120,194 the year before. That is a decrease of 37.6% compared with the year before. Equity amounted to DKK 219,320,550. The solvency ratio was 95.7%.
- Gross Profit
- 39,918,221 kr.
- Profit/Loss
- 31,081,178 kr.
- Equity
- 219,320,550 kr.
- Total Assets
- 229,116,863 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 39.9 mio. | 31.1 mio. | 219.3 mio. | - |
| 2015 | - | 64 mio. | 50.1 mio. | 188.2 mio. | - |
| 2014 | - | 58.4 mio. | 45.5 mio. | 138.1 mio. | 0 |
| 2013 | - | 48.4 mio. | 29.7 mio. | 92.6 mio. | 28 |
| 2012 | - | 37.9 mio. | 22 mio. | 63 mio. | 36 |
How creditworthy is PROXEON BIOSYSTEMS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
PROXEON BIOSYSTEMS ApS has published its annual report for 2015. Gross profit came to DKK 63,955,772, and the net result was DKK 50,120,194.
About PROXEON BIOSYSTEMS ApS
PROXEON BIOSYSTEMS ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Lie. The company is owned by NUNC A/S. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 2,950,000 compared with DKK 3,703,000 the year before. Equity amounted to DKK 386,590,000.
